FTSE All-Share
|
5 317,66
|
0,70
|
0,01 %
|
Analysen zu FTSE All-Share-Werten
| 02.10.24 | National Grid Buy | Deutsche Bank AG | |
| 02.10.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.10.24 | London Stock Exchange Outperform | RBC Capital Markets | |
| 01.10.24 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 01.10.24 | Unilever Overweight | JP Morgan Chase & Co. | |
| 01.10.24 | London Stock Exchange Buy | Goldman Sachs Group Inc. | |
| 30.09.24 | London Stock Exchange Buy | Jefferies & Company Inc. | |
| 30.09.24 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 30.09.24 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 27.09.24 | London Stock Exchange Outperform | RBC Capital Markets | |
| 26.09.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 26.09.24 | BP Buy | Goldman Sachs Group Inc. | |
| 26.09.24 | Shell Buy | Goldman Sachs Group Inc. | |
| 25.09.24 | Unilever Sell | UBS AG | |
| 25.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.09.24 | Diageo Sell | Goldman Sachs Group Inc. | |
| 24.09.24 | BP Buy | Jefferies & Company Inc. | |
| 24.09.24 | BP Underweight | JP Morgan Chase & Co. | |
| 24.09.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 24.09.24 | Shell Buy | Jefferies & Company Inc. | |
| 23.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | BP Overweight | Barclays Capital | |
| 23.09.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 20.09.24 | Unilever Overweight | JP Morgan Chase & Co. | |
| 20.09.24 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 20.09.24 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.09.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 18.09.24 | GSK Buy | Jefferies & Company Inc. | |
| 18.09.24 | BAT Buy | Deutsche Bank AG | |
| 18.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 16.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 16.09.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 16.09.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.09.24 | AstraZeneca Sell | UBS AG | |
| 13.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.09.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 12.09.24 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.